外周血单个核细胞
转录组
生物
疾病
基因表达谱
细胞毒性
外周血
发病机制
流式细胞术
自然杀伤细胞
基因表达
Wnt信号通路
计算生物学
NKG2D公司
免疫学
细胞
基因
全血
CD44细胞
细胞因子
细胞生物学
基因表达调控
外围设备
作者
Hui Yang,Xingjie You,Caibin Yue,Xiao Yu,Xinyi Yue,Xiaolei Zheng,Xiao-Hong Yan,Jiatong Li,Jianzhong Bi,Leisheng Zhang,Leisheng Zhang,Ping Wang
标识
DOI:10.1177/13872877251390553
摘要
Background Alzheimer's disease (AD) has been recognized as the most common neurodegenerative disease. Despite immunodysregulation being involved in AD pathogenesis, the systematic and detailed dissection of the cellular and transcriptomic characteristics of natural killer cells (NKs) in peripheral blood of AD patients is largely obscure. Objective To investigate the cytophenotypic and transcriptomic features of NKs in peripheral blood of AD patients. Methods We used flow cytometry assay, co-culturing, RNA-SEQ, multifaceted bioinformatics analyses (e.g., GSEA, GO, KEGG, PCA), and ELISA and qRT-PCR analysis for the comparison of the cytophenotypic and transcriptomic signatures of heathy donors-NKs (HD-NKs) and AD-NKs. Results Compared with HD-NKs, AD-NKs showed increase in the content of NKs in peripheral blood mononuclear cells (PBMCs). After a 14-day ex vivo expansion and activation, the content of AD-NKs also revealed a significant increase. Expanded AD-NKs exhibited higher cellular viability and cytotoxicity than HD-NKs. Both HD-NKs and AD-NKs revealed conservations in gene expression profiling and genetic variations, yet with multifaceted variations in diverse gene sets and the concomitant biological processes (e.g., nerve structural organization, negative regulation of immune, Wnt signaling pathway, cytotoxicity against tumor cell lines). Compared to HD-NKs, AD-NKs revealed abnormally high levels of neuroinflammation-related gene expression and cytokine secretion. Conclusions Collectively, our data indicated the similarities and variations between HD-NKs and AD-NKs both at the cellular and transcriptomic levels, which would supply new references for further dissecting the pathogenesis of AD from the aspect of NKs and benefiting the development of novel therapeutic regimens in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI